SARS-Cov-2-related lung pathology: macroscopic and histologic features and their clinical implications

The ongoing global Coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome Coronavirus 2 (SARSCoV-2), has been posing challenges to proper patients' management. Lungs are the first, and often the most affected organ by SARS-CoV-2; viral infection involves and damages both epithelial and vascular compartments, sometimes leading to severe and even fatal acute respiratory distress syndrome. Histopathological findings, mainly from post-mortem examination of COVID-19 deceased patients, have been increasingly published in the last few months, helping to elucidate the sequence of events resulting in organ injury and the complex multifactorial pathogenesis of this novel disease. A multidisciplinary approach to autopsy, including light microscopy examination along with the detection of viral proteins and/ or RNA in tissue samples through ancillary techniques, provided crucial information on the mechanisms underlying the often-heterogeneous clinical picture of COVID-19.

Automated summary

The ongoing COVID-19 pandemic has posed challenges in patients' management, particularly in relation to lung damage caused by SARS-CoV-2. Post-mortem examination of deceased COVID-19 patients has provided insights into organ injury and the complex pathogenesis of the disease. A multidisciplinary approach to autopsy has been crucial in understanding the heterogeneous clinical picture of COVID-19.